Dr. Andreas Roos wins Emerging Myologist of the Year Prize at WMS 2023

Published: 17 October 2023

We are excited to congratulate Dr. Andreas Roos on winning the World Muscle Society’s (WMS) President’s Prize for Emerging Myologist of the Year!  

This award (formerly the President’s Prize for Young Myologist of the Year) recognizes outstanding contributions and innovation from an up-and-coming researcher in the field of myology. This year’s award highlights Dr. Roos’s exceptional portfolio of recent work, commending in particular his presentation at the conference on the identification of FILIP1 variants as a novel genetic cause for a neuropediatric disease with muscle involvement. Dr. Roos’s prolific output has resulted in a career total of almost 150 publications to date, and the FILIP1 manuscript is the latest of over 50 that Dr. Roos has published together with our group.  

Dr. Andreas Roos’s publication “Bi-allelic variants of FILIP1 cause congenital myopathy dysmorphism and neurological defects”

Dr. Roos is based at the Department of Neuropaediatrics of the Universitätsklinikum Essen in Germany and holds an adjunct professorship at uOttawa. He has been a long-time collaborator with our lab on joint projects on myotonic dystrophy, GNE myopathy, gene discovery and proteomic profiling in neuromuscular disease and has also consistently been involved in international research collaborations spanning a variety of diseases and techniques.

Congratulations Dr. Andreas Roos, World Muscle Society Emerging Myologist of the Year!

Dr. Andreas Roos receiving Emerging Myologist of the Year prize at World Muscle Society congress 2023.

Photo by World Muscle Society / World Muscle Society Congress 2023.

Dr. Andreas Roos receiving award on WMS 2023 stage, with text reading Congratulaions Dr. Andreas Roos, WMS President's Prize for Emerging Myologist of the Year 2023.

Read next...

award winners

Celebrating Lab Members’ Recent Research Awards

We are thrilled to celebrate Kelly Ho for receiving first place for her poster presentation at this year’s American Society for Pharmacology and Experimental Therapeutics...
New publication - RTD (2)

Meet The Lochmüller Lab’s Newest Members!

Our research team is growing! We are excited to introduce three new members who have recently joined the Lochmüller lab and several students who will...
McMillan smart study (1)

New Clinical Study Examines Safety and Efficacy of IV Onasemnogene Abeparvovec in Broad SMA Cohort

Pediatric neurologist Dr Hugh McMillan publishes clinical study examining the safety and efficacy of IV onasemnogene abeparvovec in the broadest cohort of SMA patients to...
Text reading: Solve-RD publication: Solve-RD flagship publication: Genomic reanalysis of a pan-European rare-disease resource yields new diagnoses. Photos of Dr Kiran Polavarapu, Dr Rachel Thompson, Dr Hanns Lochmüller.

Solve-RD flagship publication in Nature Medicine: Genomic reanalysis of a pan-European rare-disease resource yields new diagnoses

Patients and families with rare disorders often remain without a genetic diagnosis despite modern advances in diagnostic testing. Due to the rarity and global distribution...
New publication: Identifies Novel ATP2A2 Variant as Genetic Cause of Dominant Rhabdomyolysis . Author's photos on the right, diagram from paper underneath title.

New Lab Publication Identifies Novel ATP2A2 Variant as Genetic Cause of Dominant Rhabdomyolysis

Rhabdomyolysis is an acute failure of cellular homeostasis characterized by acute skeletal muscle damage triggered by trauma, infection, drugs, or strenuous exercise. Recurrent rhabdomyolysis is...
New lab publication on riboflavin transporter deficiency model

New Publication: Development of a riboflavin-responsive model of riboflavin transporter deficiency in zebrafish

Riboflavin transporter deficiency (RTD) is a rare genetic disorder in children, characterised by progressive sensorimotor and cranial neuronopathy caused by mutations in riboflavin transporter protein-encoding...